Co-Diagnostics Balance Sheet Health
Financial Health criteria checks 6/6
Co-Diagnostics has a total shareholder equity of $63.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $72.4M and $8.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$37.66m |
| Equity | US$63.78m |
| Total liabilities | US$8.60m |
| Total assets | US$72.38m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: C97's short term assets ($40.1M) exceed its short term liabilities ($5.8M).
Long Term Liabilities: C97's short term assets ($40.1M) exceed its long term liabilities ($2.8M).
Debt to Equity History and Analysis
Debt Level: C97 is debt free.
Reducing Debt: C97 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: C97 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: C97 has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 16.9% each year.